Metabolic basis of aminonucleoside nephrosis in rats. I. Inhibition of alpha-oxoglutarate oxidation by aminonucleoside.
D000255:Adenosine Triphosphate / Q000032:analysis; D000818:Animals; D002262:Carboxy-Lyases / Q000378:metabolism; D002951:Citrates / Q000032:analysis; D002952:Citric Acid Cycle / Q000187:drug effects*; D003065:Coenzyme A / Q000494:pharmacology; D005977:Glutarates / Q000037:antagonists & inhibitors* / Q000378:metabolism; D006150:Guanine Nucleotides / Q000494:pharmacology; D066298:In Vitro Techniques; D007668:Kidney / Q000187:drug effects / Q000201:enzymology / Q000378:metabolism*; D008190:Lyases / Q000378:metabolism; D008297:Male; D008928:Mitochondria / Q000378:metabolism; D009243:NAD / Q000494:pharmacology; D009404:Nephrotic Syndrome / Q000139:chemically induced* / Q000378:metabolism; D009705:Nucleosides / Q000494:pharmacology*; D010071:Oxaloacetates / Q000032:analysis / Q000096:biosynthesis; D011691:Puromycin; D011773:Pyruvates / Q000096:biosynthesis; D051381:Rats
D002951:Citrates; D005977:Glutarates; D006150:Guanine Nucleotides; D009705:Nucleosides; D010071:Oxaloacetates; D011773:Pyruvates; D009243:NAD; D011691:Puromycin; D000255:Adenosine Triphosphate; D008190:Lyases; D002262:Carboxy-Lyases; D003065:Coenzyme A